Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Sulfonylated Indanone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Cu-catalyzed route for 3-sulfonylated-indanones. High yield, mild conditions. Cost-effective manufacturing for pharmaceutical intermediates.
Patent CN108689892B discloses a novel CuI-catalyzed route for 3-sulfonylated indanones, offering mild conditions and high yields for cost-effective pharmaceutical intermediate manufacturing.